PRESBYOND in China — the presbyopia LASIK you were quoted by name
Platform and trial facts researched September 2026 · Prices researched July 2026 · Published September 2026
PRESBYOND is not a machine and not a country-level yes-or-no. It is a ZEISS planning-software option that treats on the MEL 90 excimer laser, so “is it available in China” collapses into a question about one hospital: does this department have a MEL 90, and is the presbyopia software licensed on it. Two hard facts say the procedure is genuinely present in the mainland rather than only in the region around it — ZEISS has trained Chinese refractive centres on it through a national MEL 90 programme, and Zhongshan Ophthalmic Center in Guangzhou is recruiting right now for a randomised head-to-head against conventional monovision LASIK. This page gives you the platform question to ask, the trial that is testing the central claim, the aviation complication, the limit that disqualifies more people than thin corneas do, and why we refuse to print a PRESBYOND price band.
Why your quote names a brand you cannot find in China
If you are in your forties or fifties and have looked at laser vision correction, you have probably been quoted PRESBYOND Laser Blended Vision by name — from a clinic in London, Singapore, Kuala Lumpur, Hong Kong or Taipei, all of which market it heavily in English. Then you start pricing China, and the name vanishes. Chinese hospital pages, and the English medical-travel aggregators writing about them, talk about SMILE and LASIK and ICL and go quiet on presbyopia entirely.
That silence is a marketing artefact, not a clinical one, and it has a specific cause. The procedure is a software licence on an excimer laser, not a headline machine a hospital builds a webpage around. ZEISS describes PRESBYOND as an option for the CRS-Master and Refractive Workplace planning systems that treats on the MEL 90 platform. A Chinese refractive department advertises the VisuMax, because SMILE volume is what fills its theatres; the MEL 90 sitting beside it, and whether the presbyopia module is unlocked on it, is a detail nobody thought to put in English.
So the useful question is not “does China have PRESBYOND”. It is “does this hospital have a MEL 90 with the presbyopia software licensed, and who there has used it”. That is answerable in one email, and the rest of this page is about what to do with the answer.
What we can actually verify about China availability
We would rather show you the evidence than assert a conclusion, because the evidence here is thinner than a clinic brochure would imply and its shape matters.
ZEISS is training Chinese refractive centres on it. The company has run a national MEL 90 education programme for refractive departments across China, and a Chongqing ophthalmology team was invited to present its own clinical experience with PRESBYOND presbyopia surgery within it, alongside published case discussions of blended-vision presbyopia treatment in Chinese. A manufacturer does not build national training around a module nobody has bought, and a hospital does not present a case series on a procedure it has not performed.
A Chinese academic centre is running a randomised head-to-head. This is the strongest single item and it is discussed in its own section below.
What we could not verify, stated as plainly as the rest. We found no English-language source naming a specific mainland Chinese hospital and its PRESBYOND capability, and no published Chinese national volume figure for presbyopia laser treatment. The consumer-facing English supply for this procedure is overwhelmingly Taiwanese, Hong Kong, Singaporean, Malaysian and British. That absence is why we are not publishing a list of centres: a list we cannot source is worth less than an honest instruction to ask.
The Guangzhou trial — and why we are telling you about it
The central marketing claim for PRESBYOND is that it is better than ordinary monovision. That claim is currently being tested in a randomised trial in China.
Zhongshan Ophthalmic Center at Sun Yat-sen University in Guangzhou is recruiting for a randomised clinical study comparing PRESBYOND Laser Blended Vision against conventional monovision LASIK in people with presbyopia (ClinicalTrials.gov identifier NCT07512089, registration last verified March 2026, study start 12 May 2026). Two things follow, and they point in opposite directions, which is why we would rather you had both.
It is the most concrete evidence available that the procedure is established in mainland China. A leading academic eye centre does not randomise patients onto a treatment arm it cannot deliver routinely. Whatever the English-language internet says, PRESBYOND is being performed in Guangzhou to a standard that satisfies an institutional review board.
And it tells you how settled the superiority question is: not very. If the advantage over plain monovision were large, obvious and established, nobody would still be randomising patients to find out in 2026. That is not a criticism of the procedure — it is what an honest reading of an active trial means, and it should temper any clinic that presents the comparison as closed.
Blend zone, not monovision — the mechanism, in plain terms
Understanding the difference is what lets you evaluate a quote, so it is worth two minutes.
Conventional monovision corrects one eye for distance and the other for near, and hands your brain two images that disagree. The usual adaptation is suppression: you stop attending to one eye for one task. Many people manage this well. The common complaints are the intermediate range — a dashboard, a laptop — falling into a gap between the two settings, and a loss of fine depth perception that people notice most when driving at night or pouring something.
PRESBYOND targets a different optical outcome. It uses a non-linear aspheric ablation profile to increase the depth of focus of each eye individually, then sets a deliberately small difference between the two — micro-monovision, a fraction of what conventional monovision uses. Because each eye now covers a wider range, the two ranges overlap rather than butting up against each other, and the overlap is the “blend zone” the brand name refers to. The intended result is one fused image across distance, intermediate and near, rather than two competing ones your brain has to choose between.
Two honest qualifications belong immediately next to that description. It is a design intent, and whether your visual system delivers it is individual — the fusion is done by your brain, not by the laser. And the wider depth of focus is bought with optical compromise: increasing depth of focus by manipulating aberration is not free, and some people trade a small amount of crispness at distance for the range. A surgeon who explains that trade before you ask is a good sign.
The limit that disqualifies more people than thin corneas
On most laser vision pages, including several on this site, the gatekeeping measurement is corneal thickness. Here it is neural adaptation, and it is a different kind of limit because it is a fact about you rather than about your cornea.
The whole design depends on your visual system fusing two slightly dissimilar images into one comfortable percept. Most people can. Some cannot, and no scan predicts which you are. The standard way to find out is a simulation trial before the decision — usually contact lenses set to approximate the planned blend, worn through ordinary life for a period rather than judged in a consulting room. If a centre offering you PRESBYOND does not propose a simulation, ask why. It is the cheapest, most informative step in the entire pathway, it is reversible, and its absence from a quote is more revealing than any price.
The other limit is anatomical and it decides between two different surgeries rather than two laser plans. Where the natural lens has already begun to lose optical quality — early cataract, or the dysfunctional-lens changes common past about sixty — a corneal procedure is treating the wrong structure. Reshaping the cornea does nothing about a lens that is clouding, and the correction may be overtaken within a few years by the lens change underneath it. In that situation a lens-based route is usually the more durable answer.
Pilots, Class 1 certification, and a warning about general answers
A pilot in their mid-forties watching the approach plate go soft is one of the sharpest versions of this problem, and it is the version where a general answer is most dangerous.
The procedure has been studied in exactly this population: there is a published series on PRESBYOND laser blended vision in commercial and military pilots requiring Class 1 medical certification. We name it so you know the literature exists and can take it to your own examiner; we have not read that paper in full and we are quoting no result from it, which is a rule we apply to every source on this site rather than a caveat invented for this one.
What we can tell you is the shape of the problem. Aviation authorities regulate refractive surgery through post-operative waiting periods, refractive stability requirements, and standards for binocular function and depth perception — and the FAA, EASA and CAAC do not write those rules identically. A procedure that intentionally leaves your two eyes slightly different engages the binocular-function clauses in a way that ordinary distance-only correction simply does not. That is the precise reason a friend’s experience, a clinic’s reassurance or a forum post is not usable here.
The order that protects you: ask your aeromedical examiner what your issuing authority requires, in writing, before you book anything. A quoted surgery date is not worth a certificate. We can tell you what a Chinese hospital will do; nobody but your regulator can tell you what it will accept.
What it costs — and why there is no PRESBYOND band on this page
Every other procedure on this site carries a dated range. This one does not, and the reason is worth stating because it is the same reason you should distrust any range you are shown.
PRESBYOND is a treatment plan delivered on the LASIK platform family, so our dated LASIK rate is the honest anchor: $1,200–1,800 for both eyes at standard partner-hospital rates, researched July 2026, consistent with our homepage table. On top of that, centres may add a premium for the presbyopia planning software and the additional pre-operative work — and we have not been able to verify a consistent, published mainland-China premium across enough centres to print as a range. A range we invented would be worse than none, because you would carry it into a negotiation as though it were a benchmark.
So: treat any presbyopia-plan premium as centre-set, and require it as its own line in a written quote, next to the named excimer platform. A quote that gives you one total and no breakdown cannot be compared with anything.
| Procedure | Both eyes, standard partner-hospital rate | Status on this page |
|---|---|---|
| LASIK | $1,200–1,800 | The anchor for a PRESBYOND plan — same platform family |
| TransPRK | $1,000–1,500 | Surface ablation; not a presbyopia plan |
| SMILE | $2,200–2,900 | Different laser (VisuMax); not the PRESBYOND platform |
| EVO ICL | $3,800–4,800 | Phakic lens; a separate route, not blended vision |
| PRESBYOND premium | Not published — centre-set | Ask for it as a separate line in writing |
Rates researched July 2026 and consistent with the homepage table. Platform and trial facts researched September 2026. A written individual quote follows your diagnostic workup.
The realistic expectation, stated the way a surgeon would
Two things are true at once, and clinics tend to publish only the first.
Presbyopia is progressive, and surgery does not stop it. Your natural lens keeps stiffening after the procedure. A plan that is comfortable at forty-eight is being asked to do more at fifty-eight, and some people who were spectacle-free early return to readers for small print or poor light later. That is not a complication; it is the condition continuing.
And the evidence base for laser presbyopia correction is weaker than the marketing. The standing criticism in review literature on laser presbyopia treatment as a class is the scarcity of long follow-up and the absence of standardised outcome measures — which is why success rates quoted by different clinics are not comparable and are easy to select favourably. The Guangzhou randomisation is a direct response to that state of affairs.
The framing that survives both facts: the realistic aim is reduced dependence on reading glasses across most everyday tasks, not their elimination. A surgeon who says that is describing the procedure. One who guarantees anything is not describing it at all, and candidacy and the final plan are determined by the operating surgeon from your own measurements.
Questions people actually ask
Is PRESBYOND laser blended vision available in China?
In practice the answer is decided by the individual hospital, not by the country. PRESBYOND is not a separate machine — it is a ZEISS software option that runs on the CRS-Master or Refractive Workplace planning system and treats on the ZEISS MEL 90 excimer laser. So the real question is whether a given Chinese refractive department has a MEL 90 and has licensed the presbyopia software on it, and that is a centre-level fact you can ask for by name. Two things tell us it is genuinely present in the mainland market rather than only in the region around it: ZEISS has run a national MEL 90 training programme for Chinese refractive centres in which a Chongqing team presented its own clinical experience with PRESBYOND presbyopia surgery, and Zhongshan Ophthalmic Center in Guangzhou is currently recruiting for a randomised trial comparing PRESBYOND against conventional monovision LASIK. Neither of those happens around a procedure nobody performs. What we could not find anywhere is an English-language page that names a specific mainland Chinese hospital and its PRESBYOND capability, which is why this page tells you what to ask instead of publishing a list we cannot stand behind.
What is the difference between PRESBYOND and ordinary monovision LASIK?
Conventional monovision sets one eye for distance and the other for near and leaves your brain to pick between two competing images, usually by suppressing one. It works for a substantial minority of people and is disliked by others, mostly because of the gap in the middle and the loss of depth perception. PRESBYOND aims at a different optical result: it uses a non-linear aspheric ablation profile to deliberately increase each eye's depth of focus, then sets only a small difference between the two eyes — micro-monovision rather than monovision. The intended consequence is that the two eyes' ranges overlap instead of competing, producing a continuous 'blend zone' the brain fuses into one image across distance, intermediate and near. That is the theory and it is the reason the procedure exists. Whether it beats plain monovision by enough to matter for you is exactly what the Guangzhou trial described on this page was set up to measure, which should tell you how settled the question is.
Who is not a candidate for PRESBYOND?
Every standard laser-vision contraindication applies unchanged — keratoconus or other corneal ectasia, corneal dystrophy, active inflammatory or infectious eye disease, poorly controlled autoimmune disease or diabetes, significant dry eye, and corneas too thin for the planned ablation. Beyond those, two limits are specific to this procedure. The first is neural adaptation: the whole design depends on your visual system fusing two slightly different images, and not everyone's does. Surgeons screen for this before operating, commonly with a contact-lens trial that simulates the plan, and a poor result on that trial is a reason not to proceed rather than a hurdle to push through. The second is age and lens status. Where the natural lens has already begun to cloud or lose its optical quality, a corneal procedure is treating the wrong structure, and a lens-based route is usually the more durable answer — which is why PRESBYOND is less often recommended past about sixty. Candidacy is determined by the operating surgeon from your own diagnostic workup, and no online screen replaces it.
Can pilots have PRESBYOND and keep a Class 1 medical certificate?
This is a real question with a real literature behind it — there is a published series specifically on PRESBYOND laser blended vision in commercial and military pilots holding Class 1 certification — and it is also a question no website should answer for you, including this one. Aviation authorities regulate refractive surgery by procedure, by post-operative waiting period, by stability requirements and by binocular-function standards, and the rules differ between the FAA, EASA and CAAC. A procedure that deliberately leaves your two eyes slightly different engages the binocular-function part of those standards in a way that ordinary distance-only correction does not, so this is precisely the case where the general answer and your answer can diverge. The correct order is to ask your aeromedical examiner what the authority that issues your certificate requires, in writing, before you book anything. We can tell you what a Chinese hospital will do; we cannot tell you what your regulator will accept.
How much does PRESBYOND cost in China?
We do not publish a PRESBYOND-specific price band, and we would rather say that plainly than invent one. PRESBYOND is a treatment plan delivered on the LASIK platform family, so our dated LASIK rate is the honest starting point: $1,200–1,800 for both eyes at standard partner-hospital rates, researched July 2026 and consistent with our homepage table. What we have not been able to verify is a consistent, published mainland-China premium for the presbyopia software plan across enough centres to be worth printing as a range — and a made-up range is worse than none, because you would negotiate against it. Treat any presbyopia-plan premium as centre-set, ask for it as its own line in your written quote alongside the platform name, and read the quote against the band above.
Will PRESBYOND get me out of reading glasses permanently?
No procedure can promise that, and the honest framing has two separate parts. The first is that presbyopia is progressive: your natural lens continues to stiffen after surgery, so a plan that works comfortably at forty-eight is being asked to do more at fifty-eight, and some people who were spectacle-free early return to glasses for small print or dim light later. The second is that the evidence base for laser presbyopia correction as a whole is weaker than the marketing implies — the standing criticism in the review literature is the scarcity of long follow-up and the absence of standardised outcome measures, which makes clinic-to-clinic success figures hard to compare and easy to quote selectively. A surgeon who tells you the aim is to reduce dependence on reading glasses for most everyday tasks is describing the procedure accurately. One who guarantees you will never need them is not.
Is PRESBYOND the same as SMILE for presbyopia?
No, and confusing them will send you to the wrong department. PRESBYOND is an excimer-laser LASIK treatment plan on the MEL 90; SMILE is a femtosecond lenticule procedure on the ZEISS VisuMax, and the two are different operations on different machines. China is the world's largest SMILE market, which means many Chinese refractive departments are organised around the VisuMax first — so a hospital with outstanding SMILE credentials is not automatically a hospital with a licensed MEL 90 presbyopia programme. This is the single most useful thing to know before you enquire: ask about the excimer platform and the presbyopia software specifically, rather than assuming a strong refractive department covers both.
What should I ask a Chinese hospital before booking a presbyopia laser procedure?
Five questions, and all five belong in writing rather than in a chat window. Which excimer laser will treat me, by manufacturer and model? Is the presbyopia planning software licensed on that machine at this site, and what is it called? How many presbyopia laser cases has the operating surgeon performed, and over what period? Will I have a simulation trial — usually contact lenses — before the decision, and what result would make you advise against proceeding? And what is the total price, with any presbyopia-plan premium shown as its own line? A centre that answers all five specifically is telling you a great deal about how it works. A centre that answers only the last one is telling you something too.